By Dr. Ozempic McMuffin, Nutritional Litigation Correspondent March 3, 2026 – Washington, D.C.
WASHINGTON—In a landmark settlement that will rewrite every middle-school health textbook for the next decade, the U.S. Department of Agriculture has officially retired the food pyramid after 33 years of service and replaced it with the Food Rhombus—a shape Big Pharma’s lawyers successfully argued was “the only geometric figure capable of accommodating semaglutide as a foundational food group.”
The lawsuit, filed jointly by Novo Nordisk, Eli Lilly, Pfizer, and a shadowy consortium of weight-loss-injectable manufacturers, claimed the traditional pyramid’s triangular structure “discriminated against pharmaceuticals” by excluding them from the base. “The pyramid is exclusionary,” read the 1,400-page complaint. “It privileges carbohydrates and vegetables while marginalizing life-saving injections that literally melt fat off Americans. This is structural oppression.”
USDA Secretary Tom Vilsack, looking visibly defeated while holding a novelty rhombus-shaped pizza slice, announced the change at a press conference flanked by executives in lab coats. “After careful consideration—and several seven-figure donations—we have concluded that the Food Rhombus better reflects modern American dietary reality,” he said. “It’s not a pyramid scheme anymore. It’s a rhombus scheme.”
The new Food Rhombus guidelines divide daily nutrition into four equal sides:
- Ozempic/Wegovy/Mounjaro (Base Layer) – 40–50% of daily calories should now be replaced by weekly subcutaneous injections. “Protein, fiber, and satiety are now delivered via needle,” explained lead researcher Dr. Chad Bariatric. “Bread is optional. Tirzepatide is mandatory.”
- Ultra-Processed Snack Dust – The right side of the rhombus is dedicated to the colorful dust left at the bottom of chip bags, now reclassified as “micronutrient delivery systems.”
- Energy Drinks & Diet Coke – Left side. Because hydration is for quitters.
- Regret & Self-Loathing – The top point, to be consumed in moderation but almost always exceeded.
Nutritionists who dared criticize the change were quickly labeled “anti-science” and “body-positive extremists.” The American Heart Association issued a mild statement of concern, then immediately accepted a $12 million research grant from Eli Lilly “to study the cardiovascular benefits of rapid weight loss via GLP-1 agonists.”
Social media erupted with memes of the old pyramid weeping while the rhombus flexed in the mirror, caption: “When your food guide gets on Ozempic and starts gatekeeping carbs.”
As of today, every public-school lunch tray must now include a QR code linking to a free trial of Wegovy, and the USDA’s official motto has been updated to: “MyPlate? Nah. MyRhombus.”
Big Pharma’s next target: allegedly suing the MyPlate initiative to become the MyParallelogram so statins can finally get equal billing with kale.
The rhombus is here. Resistance is futile. Your pancreas already surrendered.
